
Enzo Willcox

AstraZeneca tumbles, Schott Pharma raises its ambitions
Healthcare is in the spotlight today: AstraZeneca fails a phase 3 trial for a cardiac treatment. By contrast, Computacenter is pointing to a near-doubling of profit, while Capgemini is punished in the stock market after a Citigroup rating change.
July 09, 2026 at 08:44 am
Hermes at 1,600 euros: what if real luxury is somewhere else?
The recent pullback in luxury has created genuine buying opportunities. Yet the price of entry into the industry's giants remains high. A closer look at three companies with compelling profiles, ideally positioned if financial flows return.
July 03, 2026 at 01:55 pm
Hong Kong: The Ugly Duckling of Tech
While Japan, Taiwan, and South Korea dominate the market spotlight, Hong Kong has been languishing since the start of the year. The Hang Seng is down 10%, placing it at the back of the pack among major global indices.
June 25, 2026 at 03:29 pm

Medpace: At the Heart of the Small-Cap Biopharma Crisis
Caught between solid fundamentals and a lagging stock price, the clinical testing firm is paying the price for earnings reports that signal a slowdown in orders. The situation is further complicated by management's uncharacteristic delay in launching share buybacks, a move that usually reassures the market, although which has yet to materialize this time around.
June 17, 2026 at 09:12 am

When AI hides in the restroom: the best-kept secret in Japanese tech
Driven by an ultra-profitable yet niche ceramic segment, Japan's TOTO is navigating a stark divide between the Chinese real estate crisis and the semiconductor boom. As activist fund Palliser recently unveiled the company's near-monopoly on a key technology, the stock still offers a fundamentally undervalued entry point to play… AI infrastructure!
June 11, 2026 at 10:12 am
Hugo Boss Shines While Camurus Faces Delays
Shifting analyst recommendations are driving market movement, with Kontron benefiting from a modest premium. Bank of America has reaffirmed the positive trend for ASM, while Halma shares tumbled despite solid earnings. Meanwhile, Camurus is lagging following a delay in the approval of its acromegaly treatment.
June 11, 2026 at 09:11 am
Rational: A Busy Roadmap for the Chefs' Workshop
Already a staple in our restaurants, Rational is playing a clever game: 3/4 of the global market still eludes it. While the stock is currently treading water amid geopolitical and trade tensions, the German group's solid fundamentals point towards an impressive long-term expansion.
June 03, 2026 at 03:17 pm
Technoprobe: A tech gem priced for perfection
After several years of stagnation, the Italian group is returning to growth. Investors have taken note of this, driving the stock well beyond its previous peaks. However, trading at over 72x earnings, there is no room for error.
June 03, 2026 at 11:11 am
Inditex Gains Ground, Partners Group Limits Withdrawals
The parent company of Zara reported a surge in sales. Sodexo and Veolia benefited from Barclays' recommendations, while Norwegian Air Shuttle struggled following a downgrade from Danske Bank. Clas Ohlson posted disappointing results.
June 03, 2026 at 09:14 am
UniCredit cleared to raise Commerzbank stake beyond 30%
By preparing to cross the critical 30% ownership threshold, UniCredit is seizing the reins in its standoff with Commerzbank. This shift hands the Italian lender full control of the timeline. The balance of power has flipped; the ball is now in Milan's court.
June 02, 2026 at 01:59 pm
UniCredit Cleared to Exceed 30% Stake in Commerzbank
By preparing to cross the critical 30% ownership threshold, UniCredit is seizing the levers of control in its pursuit of Commerzbank. This shift grants the Italian lender mastery over the timeline, effectively reversing the balance of power: the ball is now in Milan's court.
June 02, 2026 at 10:25 am
Aspeed: The Small Chip Essential to the World's Supercomputers
A stock that has surged over 500% in a year, margins exceeding 50%, a central position in AI infrastructure, and yet a single technology dominated by this Taiwanese company. This is the recipe that has driven Aspeed's success, long before its 2013 IPO.
June 01, 2026 at 10:36 am
Copart Running on Empty: Why the Cash Machine Has Stalled
After a decade of insolent growth, Copart's formidable engine appears to be seizing up. The global leader in vehicle salvage is facing an investor exodus, fueled by concerns over thinning volumes. Yet, with a debt-free balance sheet and a valuation that has become highly attractive, the company's underlying investment case remains as compelling as ever.
June 01, 2026 at 10:18 am
Copart Running on Empty: Why the Cash Machine Has Stalled
After a decade of strong growth, Copart's formidable engine appears to be seizing up. The global leader in vehicle salvage is facing an investor exodus, fueled by concerns over thinning volumes. Yet, with a debt-free balance sheet and a valuation that has become highly attractive, the company's fundamental appeal remains intact.
June 01, 2026 at 10:03 am
Interpump: One sell-off too many?
After a spectacular rally, the stock is struggling to rediscover its growth momentum. Two consecutive years of decline, weighed on by annual results, have nevertheless brought the valuation back to an attractive level.
May 28, 2026 at 12:15 pm

Mips: The "Gore Tex" of Security is Aiming for the Top Again
Rarely has a surge in demand placed such pressure on a company. Yet, this is the paradox that Mips has faced. Following the post-Covid euphoria, an inventory glut weighed heavily on the group's fundamentals, dragging the stock down towards all-time lows. While growth is now making a strong comeback in its financial statements, the share price is still struggling to regain momentum.
May 27, 2026 at 03:01 pm
Discover our authors
Chief Editor
Journalist
Analyst
Analyst
Junior Analyst
- Stock Market
- Our authors
- Enzo Willcox


















